To include your compound in the COVID-19 Resource Center, submit it here.

Erythropoietin (EPO): Began Phase II trials

Dragon Pharmaceuticals Inc. (DRUG), Vancouver, B.C.
Product: Erythropoietin (EPO)
Business:

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE